nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—Antipyrine—CYP2A6—esophageal cancer	0.0465	0.192	CrCbGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—SNAI2—esophageal cancer	0.0462	0.0609	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—KRT14—esophageal cancer	0.0372	0.0491	CbGpPWpGaD
Methsuximide—Antipyrine—PTGS1—esophageal cancer	0.0356	0.147	CrCbGaD
Methsuximide—Phenobarbital—CYP1B1—esophageal cancer	0.0294	0.122	CrCbGaD
Methsuximide—Phenytoin—ABCC2—esophageal cancer	0.0239	0.099	CrCbGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—SFN—esophageal cancer	0.0239	0.0315	CbGpPWpGaD
Methsuximide—Phenobarbital—ABCC2—esophageal cancer	0.023	0.0949	CrCbGaD
Methsuximide—Phenobarbital—CYP2A6—esophageal cancer	0.0227	0.0938	CrCbGaD
Methsuximide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—esophageal cancer	0.0216	0.0286	CbGpPWpGaD
Methsuximide—CYP2C19—CYP2E1 reactions—CYP2A6—esophageal cancer	0.0208	0.0275	CbGpPWpGaD
Methsuximide—Antipyrine—PTGS2—esophageal cancer	0.0203	0.0841	CrCbGaD
Methsuximide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—esophageal cancer	0.0197	0.026	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—PFN1—esophageal cancer	0.014	0.0184	CbGpPWpGaD
Methsuximide—Ketazolam—ABCB1—esophageal cancer	0.0137	0.0565	CrCbGaD
Methsuximide—CYP2C19—Xenobiotics—CYP2A6—esophageal cancer	0.0129	0.017	CbGpPWpGaD
Methsuximide—CYP2C19—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.0124	0.0164	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—CFL1—esophageal cancer	0.0113	0.0149	CbGpPWpGaD
Methsuximide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.0111	0.0146	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—PFN1—esophageal cancer	0.0103	0.0136	CbGpPWpGaD
Methsuximide—CYP2C19—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.01	0.0132	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—PFN1—esophageal cancer	0.00997	0.0132	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PFN1—esophageal cancer	0.00996	0.0131	CbGpPWpGaD
Methsuximide—Clobazam—ABCB1—esophageal cancer	0.00967	0.0399	CrCbGaD
Methsuximide—CACNA1I—Axon guidance—ACTB—esophageal cancer	0.00962	0.0127	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—TLR4—esophageal cancer	0.00954	0.0126	CbGpPWpGaD
Methsuximide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00886	0.0117	CbGpPWpGaD
Methsuximide—Phenytoin—ABCB1—esophageal cancer	0.00881	0.0364	CrCbGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.00848	0.0112	CbGpPWpGaD
Methsuximide—Phenobarbital—ABCB1—esophageal cancer	0.00845	0.0349	CrCbGaD
Methsuximide—CACNA1G—Axon guidance—CFL1—esophageal cancer	0.00834	0.011	CbGpPWpGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—esophageal cancer	0.00824	0.0109	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—CFL1—esophageal cancer	0.00808	0.0107	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CFL1—esophageal cancer	0.00807	0.0107	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SOX2—esophageal cancer	0.0078	0.0103	CbGpPWpGaD
Methsuximide—CYP2C19—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00772	0.0102	CbGpPWpGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00752	0.00992	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00748	0.00986	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00742	0.00979	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—PFN1—esophageal cancer	0.00735	0.00969	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—NOS3—esophageal cancer	0.0073	0.00963	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PFN1—esophageal cancer	0.00711	0.00939	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—ACTB—esophageal cancer	0.00709	0.00936	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—BCL2—esophageal cancer	0.00702	0.00927	CbGpPWpGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—esophageal cancer	0.00696	0.00918	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ACTB—esophageal cancer	0.00687	0.00906	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ACTB—esophageal cancer	0.00686	0.00906	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CTNNA1—esophageal cancer	0.00674	0.0089	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00655	0.00865	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—ABL1—esophageal cancer	0.00644	0.0085	CbGpPWpGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—esophageal cancer	0.00641	0.00845	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00609	0.00804	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CFL1—esophageal cancer	0.00595	0.00785	CbGpPWpGaD
Methsuximide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00588	0.00776	CbGpPWpGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.00588	0.00775	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CFL1—esophageal cancer	0.00576	0.00761	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SOX2—esophageal cancer	0.00575	0.00758	CbGpPWpGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—esophageal cancer	0.00558	0.00737	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SOX2—esophageal cancer	0.00557	0.00735	CbGpPWpGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00536	0.00707	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00529	0.00697	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ACTB—esophageal cancer	0.00506	0.00668	CbGpPWpGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.005	0.00659	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CTNNA1—esophageal cancer	0.00497	0.00656	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ACTB—esophageal cancer	0.0049	0.00647	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—KDR—esophageal cancer	0.00488	0.00644	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CTNNA1—esophageal cancer	0.00482	0.00635	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MET—esophageal cancer	0.00478	0.0063	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—ABL1—esophageal cancer	0.00475	0.00626	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00462	0.00609	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ABL1—esophageal cancer	0.0046	0.00607	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ABL1—esophageal cancer	0.0046	0.00606	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SMAD4—esophageal cancer	0.00445	0.00587	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00434	0.00573	CbGpPWpGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00432	0.0057	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00426	0.00562	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00412	0.00543	CbGpPWpGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00406	0.00536	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00401	0.00529	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—ADH7—esophageal cancer	0.00397	0.00524	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—KDR—esophageal cancer	0.0036	0.00475	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MET—esophageal cancer	0.00352	0.00465	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.0035	0.00462	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—ERBB2—esophageal cancer	0.00349	0.00461	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—KDR—esophageal cancer	0.00348	0.0046	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—KDR—esophageal cancer	0.00348	0.00459	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—ADH1B—esophageal cancer	0.00348	0.00459	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MET—esophageal cancer	0.00341	0.0045	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MET—esophageal cancer	0.00341	0.0045	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ABL1—esophageal cancer	0.00339	0.00447	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00329	0.00434	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SMAD4—esophageal cancer	0.00328	0.00433	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ABL1—esophageal cancer	0.00328	0.00433	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—NOTCH1—esophageal cancer	0.00328	0.00433	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP26A1—esophageal cancer	0.00324	0.00427	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00319	0.00421	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SMAD4—esophageal cancer	0.00318	0.00419	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTO1—esophageal cancer	0.00301	0.00397	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CREBBP—esophageal cancer	0.00297	0.00392	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GSTO1—esophageal cancer	0.00297	0.00392	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—ERBB2—esophageal cancer	0.00257	0.0034	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—KDR—esophageal cancer	0.00257	0.00339	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MET—esophageal cancer	0.00251	0.00332	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ERBB2—esophageal cancer	0.00249	0.00329	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ERBB2—esophageal cancer	0.00249	0.00329	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—KDR—esophageal cancer	0.00249	0.00328	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—ALDH2—esophageal cancer	0.00245	0.00324	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MET—esophageal cancer	0.00243	0.00321	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—EGFR—esophageal cancer	0.00242	0.00319	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—NOTCH1—esophageal cancer	0.00242	0.00319	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—NOTCH1—esophageal cancer	0.00234	0.00309	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTT1—esophageal cancer	0.00233	0.00308	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP2A6—esophageal cancer	0.00231	0.00304	CbGpPWpGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.00225	0.00297	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CREBBP—esophageal cancer	0.00219	0.00289	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—PTGS1—esophageal cancer	0.00219	0.00288	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CREBBP—esophageal cancer	0.00212	0.0028	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—EP300—esophageal cancer	0.00203	0.00267	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.00186	0.00245	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ERBB2—esophageal cancer	0.00184	0.00242	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00183	0.00242	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00179	0.00237	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—EGFR—esophageal cancer	0.00178	0.00235	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ERBB2—esophageal cancer	0.00178	0.00235	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.00175	0.00231	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—EGFR—esophageal cancer	0.00173	0.00228	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—EGFR—esophageal cancer	0.00173	0.00228	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00172	0.00227	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—EP300—esophageal cancer	0.00149	0.00197	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—EP300—esophageal cancer	0.00145	0.00191	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—EGFR—esophageal cancer	0.00127	0.00168	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—EGFR—esophageal cancer	0.00123	0.00163	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00121	0.0016	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00106	0.00139	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000939	0.00124	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000939	0.00124	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00084	0.00111	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CA1—esophageal cancer	0.000799	0.00105	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000799	0.00105	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CA2—esophageal cancer	0.00073	0.000964	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000714	0.000942	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.000679	0.000896	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ADH7—esophageal cancer	0.000679	0.000896	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000671	0.000886	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.000595	0.000786	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—TYMP—esophageal cancer	0.000569	0.000751	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000554	0.00073	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALOX15—esophageal cancer	0.000539	0.000712	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTO1—esophageal cancer	0.000515	0.000679	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—TPI1—esophageal cancer	0.000515	0.000679	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDOB—esophageal cancer	0.000493	0.000651	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GAPDH—esophageal cancer	0.000475	0.000627	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CRABP1—esophageal cancer	0.000471	0.000621	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GNG7—esophageal cancer	0.000448	0.000591	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDH2—esophageal cancer	0.00042	0.000554	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTT1—esophageal cancer	0.000399	0.000526	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP2A6—esophageal cancer	0.000394	0.00052	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000393	0.000518	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ENO1—esophageal cancer	0.000374	0.000493	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGS1—esophageal cancer	0.000374	0.000493	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PSME2—esophageal cancer	0.000368	0.000486	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PSME1—esophageal cancer	0.000368	0.000486	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000322	0.000425	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP1B1—esophageal cancer	0.000318	0.000419	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP19A1—esophageal cancer	0.000299	0.000394	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMOX1—esophageal cancer	0.000273	0.00036	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000268	0.000353	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCB1—esophageal cancer	0.000262	0.000345	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000198	0.000261	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CREBBP—esophageal cancer	0.000175	0.000231	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NOS3—esophageal cancer	0.000157	0.000207	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGS2—esophageal cancer	0.000143	0.000189	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—EP300—esophageal cancer	0.000119	0.000157	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	8.82e-05	0.000116	CbGpPWpGaD
